Post-radiation inflammatory reaction controlled with thalidomide and rofecoxib.
Tan
D S W
DS
Evanson
J
J
Plowman
P N
PN
Chew
S L
SL
D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D001929:Brain Edema / Q000188:drug therapy* / Q000209:etiology*; D001932:Brain Neoplasms / Q000209:etiology / Q000532:radiotherapy*; D005260:Female; D018325:Hemangioblastoma / Q000209:etiology / Q000532:radiotherapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007783:Lactones / Q000627:therapeutic use*; D011832:Radiation Injuries / Q000188:drug therapy*; D013450:Sulfones / Q000627:therapeutic use*; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome; D006623:von Hippel-Lindau Disease / Q000150:complications*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib; D013792:Thalidomide